PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
DRDR.L vs. SWDA.L
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


DRDR.LSWDA.L
YTD Return4.03%20.46%
1Y Return15.50%26.45%
3Y Return (Ann)-6.12%9.05%
5Y Return (Ann)5.13%12.70%
Sharpe Ratio1.362.54
Sortino Ratio2.063.56
Omega Ratio1.241.49
Calmar Ratio0.484.21
Martin Ratio5.7718.59
Ulcer Index2.93%1.38%
Daily Std Dev12.53%10.05%
Max Drawdown-38.49%-25.58%
Current Drawdown-24.34%0.00%

Correlation

-0.50.00.51.00.8

The correlation between DRDR.L and SWDA.L is 0.76, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

DRDR.L vs. SWDA.L - Performance Comparison

In the year-to-date period, DRDR.L achieves a 4.03% return, which is significantly lower than SWDA.L's 20.46% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-5.00%0.00%5.00%10.00%JuneJulyAugustSeptemberOctoberNovember
1.66%
8.93%
DRDR.L
SWDA.L

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


DRDR.L vs. SWDA.L - Expense Ratio Comparison

DRDR.L has a 0.40% expense ratio, which is higher than SWDA.L's 0.20% expense ratio.


DRDR.L
iShares Healthcare Innovation UCITS ETF USD (Acc)
Expense ratio chart for DRDR.L: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%
Expense ratio chart for SWDA.L: current value at 0.20% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.20%

Risk-Adjusted Performance

DRDR.L vs. SWDA.L - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) and iShares Core MSCI World UCITS ETF USD (Acc) (SWDA.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DRDR.L
Sharpe ratio
The chart of Sharpe ratio for DRDR.L, currently valued at 1.40, compared to the broader market-2.000.002.004.006.001.40
Sortino ratio
The chart of Sortino ratio for DRDR.L, currently valued at 2.15, compared to the broader market-2.000.002.004.006.008.0010.0012.002.15
Omega ratio
The chart of Omega ratio for DRDR.L, currently valued at 1.24, compared to the broader market1.001.502.002.503.001.24
Calmar ratio
The chart of Calmar ratio for DRDR.L, currently valued at 0.47, compared to the broader market0.005.0010.0015.000.47
Martin ratio
The chart of Martin ratio for DRDR.L, currently valued at 5.98, compared to the broader market0.0020.0040.0060.0080.00100.005.98
SWDA.L
Sharpe ratio
The chart of Sharpe ratio for SWDA.L, currently valued at 2.70, compared to the broader market-2.000.002.004.006.002.70
Sortino ratio
The chart of Sortino ratio for SWDA.L, currently valued at 3.73, compared to the broader market-2.000.002.004.006.008.0010.0012.003.73
Omega ratio
The chart of Omega ratio for SWDA.L, currently valued at 1.50, compared to the broader market1.001.502.002.503.001.50
Calmar ratio
The chart of Calmar ratio for SWDA.L, currently valued at 3.91, compared to the broader market0.005.0010.0015.003.91
Martin ratio
The chart of Martin ratio for SWDA.L, currently valued at 16.97, compared to the broader market0.0020.0040.0060.0080.00100.0016.97

DRDR.L vs. SWDA.L - Sharpe Ratio Comparison

The current DRDR.L Sharpe Ratio is 1.36, which is lower than the SWDA.L Sharpe Ratio of 2.54. The chart below compares the historical Sharpe Ratios of DRDR.L and SWDA.L, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00JuneJulyAugustSeptemberOctoberNovember
1.40
2.70
DRDR.L
SWDA.L

Dividends

DRDR.L vs. SWDA.L - Dividend Comparison

Neither DRDR.L nor SWDA.L has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

DRDR.L vs. SWDA.L - Drawdown Comparison

The maximum DRDR.L drawdown since its inception was -38.49%, which is greater than SWDA.L's maximum drawdown of -25.58%. Use the drawdown chart below to compare losses from any high point for DRDR.L and SWDA.L. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-31.08%
-0.79%
DRDR.L
SWDA.L

Volatility

DRDR.L vs. SWDA.L - Volatility Comparison

iShares Healthcare Innovation UCITS ETF USD (Acc) (DRDR.L) has a higher volatility of 3.51% compared to iShares Core MSCI World UCITS ETF USD (Acc) (SWDA.L) at 2.92%. This indicates that DRDR.L's price experiences larger fluctuations and is considered to be riskier than SWDA.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%3.00%4.00%5.00%JuneJulyAugustSeptemberOctoberNovember
3.51%
2.92%
DRDR.L
SWDA.L